Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ZYDUS PHARMS USA INC

  • FDA Approval
  • Jan. 17, 2024, 09:53 UTC
  • 39
  • 0 comments

FDA approve PIMAVANSERIN

Comment Full text

UCB INC

  • FDA Approval
  • Jan. 17, 2024, 09:53 UTC
  • 42
  • 0 comments

FDA approve ZILUCOPLAN SODIUM

Comment Full text

ACTAVIS ELIZABETH

  • FDA Approval
  • Jan. 17, 2024, 09:53 UTC
  • 40
  • 0 comments

FDA approve DOXEPIN HYDROCHLORIDE

Comment Full text

DR REDDYS

  • FDA Approval
  • Jan. 17, 2024, 09:53 UTC
  • 42
  • 0 comments

FDA approve FENTANYL CITRATE

Comment Full text

SCIEGEN PHARMS INC

  • FDA Approval
  • Jan. 17, 2024, 09:53 UTC
  • 42
  • 0 comments

FDA approve OMEPRAZOLE; SODIUM BICARBONATE

Comment Full text

MYLAN LABS LTD

  • FDA Approval
  • Jan. 17, 2024, 09:53 UTC
  • 42
  • 0 comments

FDA approve DOCETAXEL

Comment Full text

KINDOS

  • FDA Approval
  • Jan. 17, 2024, 05:13 UTC
  • 43
  • 0 comments

FDA approve OXALIPLATIN

Comment Full text

REGENERON PHARMACEUTICALS

  • FDA Approval
  • Jan. 17, 2024, 02:05 UTC
  • 44
  • 0 comments

FDA approve DUPILUMAB

Comment Full text

HALOZYME THERAP

  • FDA Approval
  • Jan. 17, 2024, 02:05 UTC
  • 41
  • 0 comments

FDA approve HYALURONIDASE RECOMBINANT HUMAN

Comment Full text

EAGLE PHARMS

  • FDA Approval
  • Jan. 15, 2024, 11:24 UTC
  • 47
  • 0 comments

FDA approve BENDAMUSTINE HYDROCHLORIDE

Comment Full text
  • Previous
  • 573
  • 574
  • 575
  • 576
  • 577
  • Next

Search

News categories

  • Technical Exchange News(13116)
  • Event(6229)
  • SEC News(328524)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(183616)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin